persona-tomsk.ru


Crsp Price Target

Find the latest Crispr Therapeutics AG (CRSP) stock forecast, month price target, predictions and analyst recommendations. Wall St. Analysts Ratings & Price Target. Follow K followers. $ (%) PM 02/16/ NASDAQ | $USD | Post-Market: $ (%). CRISPR Therapeutics AG (CRSP) stock price prediction is USD. The CRISPR Therapeutics AG stock forecast is USD for March. CRISPR THERAPEUTICS AG (CRSP) Price Targets From Analysts ; , 17, $, $64, $ ; , 17, $, $64, $ On average, Wall Street analysts predict that Crispr Therapeutics Ag's share price could reach $ by Mar 6, The average Crispr Therapeutics Ag stock.

CRSP Price Targets Summary. CRISPR Therapeutics AG. Wall Street analysts forecast CRSP stock price to rise over the next 12 months. According to Wall Street. The 79 analysts offering price forecasts for CRISPR Therapeutics have a median target of , with a high estimate of and a low estimate of The. View CRISPR Therapeutics AG CRSP stock quote prices, financial information, real-time forecasts, and company news from CNN. Truist Securities analyst Joon Lee maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Buy and lowers the price target from $ to $ Benzinga Newsdesk. Mon. According to 20 analysts, the average rating for CRSP stock is "Buy." The month stock price forecast is $, which is a decrease of % from the latest. According to analysts, CRISPR Therapeutics's stock has a predicted upside of % based on their month stock forecasts. What analysts cover CRISPR. Mizuho Adjusts Price Target on CRISPR Therapeutics to $99 From $82, Maintains Buy Rating · Morgan Stanley Adjusts Price Target on CRISPR Therapeutics to $48 From. The analyst firm set a price target for expecting CRSP to rise to within 12 months (a possible % upside). 52 analyst firms have reported ratings in. See CRISPR Therapeutics AG stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading. While ratings are subjective and will change, the latest CRISPR Therapeutics (CRSP) rating was a maintained with a price target of $ to $ The current. According to analysts' consensus price target of $, CRISPR Therapeutics has a forecasted downside of % from its current price of $ Amount of.

CRSP - CRISPR Therapeutics AG ; No. of Analysts, 17, 17, 22, 20 ; Avg. Estimate, , , , Stock Price Target. High, $ Low, $ Average, $ Current Price, $ CRSP will report FY earnings on 02/18/ Yearly Estimates. Stock Price Forecast The 18 analysts with month price forecasts for CRSP stock have an average target of , with a low estimate of 30 and a high. 34 analysts offering month price forecasts for Crispr Therapeutics Ag (CRSP) have a share price target of $ This median of share price forecast. Based on analysts offering 12 month price targets for CRSP in the last 3 months. The average price target is $ with a high estimate of $ and a low. What is the CRISPR Therapeutics AG stock forecast? · CRISPR Therapeutics AG stock prediction for 1 year from now: $ (%) · CRISPR Therapeutics AG. Average Price Target ; High $ ; Average $ ; Low $ CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP updated stock price target summary. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and.

TruistSecurities analyst Joon Lee maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Buy and lowers the price target from $ to $ Based on short-term price targets offered by 22 analysts, the average price target for CRISPR Therapeutics AG comes to $ The forecasts range from a low of. CRSP | Complete CRISPR Therapeutics AG stock news by MarketWatch. View real-time stock prices and stock Crispr Therapeutics price target cut to $ from $ Crispr Therapeutics price target raised to $66 from $57 at RBC Capital February 22, TipRanks. Related Video. Final Trade: HPQ, RSG, GM, CRSP. watch now. The average one-year price target for CRISPR Therapeutics AG is $86, The forecasts range from a low of $30,3 to a high of $,

CRISPR Therapeutics AG Stock Forecast, CRSP stock price prediction. Price target in 14 days: USD. The best long-term & short-term CRISPR Therapeutics. Stock price target for CRISPR Therapeutics AG CRSP are on downside and on upside. Tomorrow Target 1, Tomorrow Target 2, Tomorrow. According to the latest long-term forecast, CRISPR Therapeutics price will hit $90 by the middle of and then $ by the end of CRISPR Therapeutics. Based on the Crispr Therapeutics AG stock forecast from 13 analysts, the average analyst target price for Crispr Therapeutics AG is USD over the next

Cathie Wood on CRISPR \u0026 Genomic Stocks

sa reserve bank | spy future

8 9 10 11 12

Copyright 2015-2024 Privice Policy Contacts SiteMap RSS